Aenorasis
Aenorasis is a private Greek pharmaceutical distributor, founded in 1998 and headquartered in Athens, that supplies medical devices, therapeutic, and diagnostic products to downstream healthcare buyers with a team of 51-100 employees.
- Company typePrivate
- Founded1998
- HeadquartersAthens, Greece
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Aenorasis does
Aenorasis is a private, for-profit pharmaceutical distribution company headquartered in Athens, Greece, founded in 1998. Per its firmographic profile, the company specializes in the distribution of medical devices, therapeutic, and diagnostic products, positioning it as a multi-category healthcare wholesaler serving the Greek market. With 51-100 employees, Aenorasis sits in the small-to-mid-cap bracket of Greek pharma/medical distribution, an industry segment that requires GDP (Good Distribution Practice) licensing, cold-chain logistics capability for therapeutics and diagnostics, and compliance with EU medical device traceability regulations.
The company's business model is inferred to follow a classic pharmaceutical/medical device wholesaler structure: sourcing products from manufacturers or upstream wholesalers, holding regulated inventory, and distributing to downstream buyers such as hospitals, clinics, retail pharmacies, and diagnostic laboratories. Revenue mechanics in this segment are typically volume-based with thin gross margins, monetized through buy-sell spreads on therapeutic SKUs and service/handling fees on specialty devices and diagnostics. No pricing models, customer logos, contract structures, or channel partnerships are publicly disclosed, and the company website returned only a loading/verification placeholder, indicating limited public-facing commercial transparency.
No information on the management team, ownership structure, funding history, M&A activity, certifications, awards, partnerships, or product portfolio is available in the input data. The absence of disclosed financials, headcount trends, or strategic milestones means that Aenorasis's operational scale, recent performance, and competitive positioning cannot be triangulated beyond the firmographic snapshot. From an investment-analyst standpoint, the company presents as a long-tenured (25+ years) but data-opaque Greek healthcare distributor whose deeper diligence will require direct outreach to obtain financials, customer mix, and growth signals.
Aenorasis firmographics
Firmographics- Name
- Aenorasis
- Website
- https://aenorasis.com
- Company type
- Private
- Founded year
- 1998
- Headcount range
- 51–100 employees
- Short description
- Aenorasis is a private Greek pharmaceutical distributor, founded in 1998 and headquartered in Athens, that supplies medical devices, therapeutic, and diagnostic products to downstream healthcare buyers with a team of 51-100 employees.
- Ownership category
- akta.pro rank
Aenorasis industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- OTC & Consumer Health Distributors (HLAIAJAC)
Keywords
Where Aenorasis is headquartered
LocationHeadquarters
- HQ city
- Athens
- HQ country
- Greece
- HQ region
- Europe
Markets served
Aenorasis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
Aenorasis product offering
Product offeringCore offering
Aenorasis is a pharmaceutical distribution company based in Athens, Greece, founded in 1998. It specializes in distributing medical devices, therapeutic products, and diagnostic products to healthcare customers. The company operates with 51-100 employees and focuses on the supply of healthcare-related products.
Differentiator
Problem solved
Functional benefit
Companies that use Aenorasis
Customer profileIdeal customer profiles1 record
Aenorasis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Aenorasis competitors and assessment
Company assessmentDirect peers
- Help Pharmaceuticals: Greek pharmaceutical distribution company with similar therapeutic product portfolio. Directly comparable as a domestic Greek pharma distributor operating at overlapping customer segments (pharmacies, hospitals) with a parallel business model.
Regional players
- Uni-Pharma: Greek pharmaceutical company combining manufacturing and distribution of therapeutic products. Comparable as a Greek peer with overlapping product portfolio in therapeutic categories and similar domestic market exposure.
- Elpen Pharmaceutical: Greek pharmaceutical manufacturer and distributor headquartered in Athens. Comparable as a Greece-based pharma player with overlapping therapeutic categories and shared customer base in the Greek market.
- Genepharm: Greek pharmaceutical company specializing in distribution of therapeutic products. Comparable as a domestic Greek peer with similar distribution business model and customer base.
- Lavipharm: Greek pharmaceutical company with distribution operations across therapeutic and consumer health categories. Comparable as a Greek-headquartered player operating in pharmaceutical distribution with similar therapeutic product focus.
Broad incumbents
- Alliance Healthcare (Walgreens Boots Alliance): European pharmaceutical wholesale and distribution business within Walgreens Boots Alliance. Comparable as a large-scale pharma distributor with similar product categories and pharmacy customer base across Europe.
- Phoenix Group: Pan-European pharmaceutical wholesale and distribution group. Comparable as a large-scale pharma distributor operating across therapeutic categories — represents both a competitor and a potential roll-up acquirer of Aenorasis.
- Celesio (McKesson Europe): European pharmaceutical distribution and pharmacy operator owned by McKesson. Comparable as a major pharma wholesaler with similar B2B distribution model, serving pharmacies and hospitals across European markets including Greece.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights3 records
Customer concentration
Aenorasis social profiles
Digital presenceAenorasis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aenorasis leadership team
Management profileNumber of profiles
Aenorasis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aenorasis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aenorasis
What does Aenorasis do?
Aenorasis is a pharmaceutical distribution company based in Athens, Greece, founded in 1998. It specializes in distributing medical devices, therapeutic products, and diagnostic products to healthcare customers. The company operates with 51-100 employees and focuses on the supply of healthcare-related products.
When was Aenorasis founded?
Aenorasis was founded in 1998. It employs 51 to 100 people.
Where is Aenorasis based?
Aenorasis is headquartered in Athens, Greece, in the Europe region.
Who are Aenorasis's main competitors?
Help Pharmaceuticals is listed as a direct peer. Regional players are Uni-Pharma, Elpen Pharmaceutical, Genepharm and Lavipharm. Broad incumbents are Alliance Healthcare (Walgreens Boots Alliance), Phoenix Group and Celesio (McKesson Europe).
Does Aenorasis have an API?
No public API is recorded for Aenorasis.
What industry is Aenorasis in?
Aenorasis's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors. Its NAICS code is 42421 and its SIC code is 5122.